Cost-effectiveness of Continuous Positive Airway Pressure Therapy for Moderate to Severe Obstructive Sleep Apnea/Hypopnea | Zendy

Najib Ayas | Zendy; J. Mark FitzGerald | Zendy; John A. Fleetham | Zendy; David P. White | Zendy; Michael Schulzer | Zendy; C. Frank Ryan | Zendy; Reza Ghaeli | Zendy; G. William Mercer | Zendy; Peter Cooper | Zendy; Michael Tan | Zendy; Carlo A. Marra | Zendy

Open Access

Cost-effectiveness of Continuous Positive Airway Pressure Therapy for Moderate to Severe Obstructive Sleep Apnea/Hypopnea

Author(s) -

Najib Ayas,

J. Mark FitzGerald,

John A. Fleetham,

David P. White,

Michael Schulzer,

C. Frank Ryan,

Reza Ghaeli,

G. William Mercer,

Peter Cooper,

Michael Tan,

Carlo A. Marra

Publication year - 2006

Publication title -

archives of internal medicine

Language(s) - English

Resource type - Journals

eISSN - 1538-3679

pISSN - 0003-9926

DOI - 10.1001/archinte.166.9.977

Subject(s) - medicine , continuous positive airway pressure , hypopnea , obstructive sleep apnea , population , cost effectiveness , quality adjusted life year , apnea , emergency medicine , intensive care medicine , polysomnography , anesthesia , risk analysis (engineering) , environmental health

Obstructive sleep apnea/hypopnea (OSAH) is a common disorder characterized by recurrent collapse of the upper airway during sleep, and is associated with an increased risk of motor vehicle crashes (MVCs). Common first-line therapy for OSAH is continuous positive airway pressure (CPAP). We assessed the cost-effectiveness of CPAP therapy vs none for the treatment of OSAH.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research